Principal Street Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-5,790
Closed -$454K – 228
2023
Q3
$454K Buy
5,790
+3,010
+108% +$252K 0.09% 159
2023
Q2
$247K Buy
2,780
+71
+3% +$6.11K 0.06% 189
2023
Q1
$220K Buy
+2,709
New +$221K 0.06% 201
2022
Q2
– Sell
-1,809
Closed -$202K – 216
2022
Q1
$202K Buy
+1,809
New +$191K 0.05% 207

Other funds holding MDT

Principal Street Partners's MDT Position: Q4 2023 in Review

Principal Street Partners sold out of Medtronic (MDT) in Q4 2023, closing a stake of 5,790 shares — an estimated $454K sold.

Principal Street Partners first reported a position in MDT in Q1 2022 and held it in 4 quarters. The position peaked at $454K in Q3 2023. 2,077 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Principal Street Partners reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • Principal Street Partners sold 5,790 Medtronic shares in Q4 2023, an estimated $454K.
  • Principal Street Partners first reported a position in Medtronic in Q1 2022 and held it in 4 quarters.
  • Principal Street Partners's Medtronic position peaked at $454K in Q3 2023.
  • 2,077 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Principal Street Partners's 13F filing for Q4 2023, filed 7 Feb 2024.